Remove Disease Remove Nuclear Medicine Remove Radiology Remove Radiopharmaceuticals
article thumbnail

Nuclear Medicine at the Centre of Radiology and Radiopharmaceuticals

Open Medscience

Nuclear medicine and the future of precise, personalised care in diagnosing and treating diseases. The post Nuclear Medicine at the Centre of Radiology and Radiopharmaceuticals appeared first on Open Medscience.

article thumbnail

Illuminating the Future: Recent Breakthroughs in Nuclear Medicine Advancements (Maharashtra, Raigarh, Sangli, Satara, Sindhudurg, Solapur, Thane, Wardha, Washim, Yavatmal)

Future Teleradiology

Teleradiology-India Introduction: Nuclear medicine continues to be at the forefront of cutting-edge technologies, pushing the boundaries of diagnostic and therapeutic capabilities. Revolutionary Radioisotopes: Expanding the Diagnostic Toolkit: Explore the latest developments in novel radioisotopes used in nuclear medicine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Carolyn J. Anderson, PhD, Receives SNMMI 2024 Georg Charles de Hevesy Nuclear Pioneer Award

Imaging Technology

Anderson , PhD, a trailblazer in nuclear medicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto.

article thumbnail

Anderson wins SNMMI's Georg Charles de Hevesy Nuclear Pioneer award

AuntMinnie

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has bestowed its Georg Charles de Hevesy Nuclear Pioneer award on Carolyn Anderson, PhD, of the University of Missouri-Columbia (MU). The award honors those who have made outstanding contributions in the field of nuclear medicine, the SNMMI said.

article thumbnail

Perspective Therapeutics Announces Exclusive License Agreement with Mayo Clinic for New Radiopharmaceutical Platform for Prostate Cancer Treatment

Imaging Technology

This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb). milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

article thumbnail

The rise of theranostics: Part 2 -- Moving into communities

AuntMinnie

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. Hope, vice chair of clinical operations and strategy in the UCSF department of radiology, established the radioligand therapy group at the university. However, few freestanding theranostics centers exist today. Hope added.